| Financial Year |
March 31 2023 |
| Monetary Funds |
1,763,911,705.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
350,424,747.56 |
| Advances to Suppliers |
12,374,648.12 |
| Other Receivables |
6,413,083.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
465,589,838.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,388,227.59 |
| Total Current Assets |
3,105,121,338.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
700,027,011.91 |
| Investment Properties |
10,476,677.14 |
| Fixed Assetes |
881,743,645.05 |
| Under-construction Projects |
18,734,799.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
167,902,162.99 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
127,732,101.90 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,910,609,759.13 |
| Total Assets |
5,015,731,097.87 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
844,171,462.15 |
| Accounts Payable |
1,424,137,682.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
124,474,613.54 |
| Taxes Payable |
16,635,659.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
215,983,393.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,098,695.24 |
| Other Current Liabilities |
39,630,994.73 |
| Sub-Total of Current Liabilities |
2,844,687,362.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
55,928,073.83 |
| Deferred Income Tax Liabilities |
10,779,819.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
324,885,001.98 |
| Total Liabilities |
3,169,572,364.13 |
| Paid-In Capital(Or Share Stock) |
331,320,600.00 |
| Capital Surplus |
563,065,233.11 |
| Surplus Reserve |
122,258,060.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
821,682,387.57 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,846,158,733.74 |
| Owner's Equity（Stockholder's Equity） |
1,846,158,733.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,015,731,097.87 |
